Zdrowie i gospodarka · 13/07/2026

FDA Proposes Changes to Drug Registration and Listing Requirements for Distributed Manufacturing Establishments

The US Food and Drug Administration (FDA) is proposing to amend regulations to allow distributed manufacturing establishments to register as a single entity, aligning with the PREVENT Pandemics Act, and to harmonize drug listing requirements for foreign establishments.